Project Grant K99ES035864
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$102K
Federal Agency
National Institute of Environmental Health Sciences
Federal Grant Program
93.113
Assistance Type
Project Grant
Place of Performance
Dayton, OH 45435, USA
Similar Awards
This federal Project Grant award, numbered R21AI183320, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The total funding amount is $256,808.00 for the project period from March 21, 2025 to February 28, 2027.
The goal of this research project is to better define the molecular mechanisms that cause and perpetuate systemic lupus erythematosus (SLE). The key focus areas include: 1)...
This Project Grant award of $1,517,519 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research program) supports research to identify the upstream drivers of type I interferon production in systemic lupus erythematosus (SLE). The project, titled "Upstream Drivers of Type I Interferons in Lupus", focuses on understanding the molecular mechanisms by which innate immune cells, such as neutrophils and monocytes, and skin cells...
This federal Project Grant award, with ID R21ES036190, was provided by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program. The goal of this $431,750 research project, running from January 2025 to January 2027, is to identify a new innate immune signaling mechanism that is triggered specifically after DNA damage has blocked transcription. The research aims to explain the mechanism by which environmental agents suppressing...
This $2,902,477 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports a study exploring remission and relapse in patients with systemic lupus erythematosus (SLE). The research aims to analyze immune cell profiles and brain function in SLE patients in long-term clinical remission to understand patient heterogeneity, identify predictors of sustained remission or flare, and reveal novel states of immune...
The University of Massachusetts Medical School was awarded a $494,929 Project Grant from the National Institute of Allergy and Infectious Diseases to study the role of Toll-like receptors, type II interferon and type III interferon in a murine model of autoinflammation. The grant will support research exploring the effector mechanisms responsible for inducing and regulating cutaneous lupus using genetically modified mice with discriminating mutations. Specifically, the researchers will use...
This $375,100 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support a research study focused on understanding the role of cyclic GMP-AMP synthase (cGAS) activation and nucleic-acid-dependent phase separation in regulating immune responses associated with systemic lupus erythematosus (SLE).
The study, led by researchers at The Johns...
The University of Colorado-Denver received a $449,000 exploratory and developmental research project grant (R21) from the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program. The grant aims to plan a future national, interdisciplinary, collaborative research network to study the exposome in autoimmune diseases, specifically rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Key activities include conducting a landscape analysis of...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $156,250 to the University of Toledo Health Science Campus Division to conduct research on how the loss of BRG1, a component of the SWI/SNF chromatin remodeling complex, impacts the response of melanocytes to ultraviolet radiation (UVR) exposure. The research aims to determine the effects on gene expression (Aim 1) and chromatin...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $793,093 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Oklahoma Medical Research Foundation (OMRF) to define the regulatory landscape of systemic lupus erythematosus (SLE) with cardiovascular disease (CVD) comorbidity.
The research project aims to systematically study thousands of SLE-associated genetic variants to identify causal regulatory elements, target genes, and cell...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $895,140 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Progentec Diagnostics Inc., a minority-owned small business located in Oklahoma City, OK. The purpose of this late-stage research project is to validate two innovative laboratory tests, the Lupus Flare Risk Index (L-FRI) and the Lupus Disease Activity Index (L-DAI), which are designed to detect immune dysregulation...